Award
Delivery Order #SPE2DR26F00FL
Delivery Order for Novolog Insulin Vials to AmerisourceBergen
Buyer
Defense Logistics Agency
Award Amount
$1,231.49
Ceiling
$1,231.49
Awarded
March 04, 2026
Period of Performance
Mar 04, 2026 – Mar 05, 2026
Identifier
SPE2DR26F00FL
NAICS
424210
This award represents a delivery order contract issued to AmerisourceBergen Drug Corp, a prominent pharmaceutical sourcing and distribution company. The contract involves the procurement of specific pharmaceutical products, specifically Novolog insulin vials at a defined concentration and volume, reflecting a targeted healthcare supply need. As a supplemental task under an existing indefinite delivery vehicle (IDV) contract for pharmaceutical distribution, this delivery order ensures timely availability of essential insulin medication. The work encompasses the prompt delivery of the ordered pharmaceutical items to a specified location within a short timeframe, supporting continuous healthcare service and patient needs. The award follows the framework of the parent IDV contract, leveraging AmerisourceBergen's expertise and infrastructure. This contract was awarded based on established agreements under the IDV vehicle, indicating no separate competitive bidding was required for this delivery order. The performance period is brief and immediate, emphasizing rapid fulfillment and delivery.
Description
4571038475!NOVOLOG 100 UNIT/ML VIAL 10ML